Overview
Leica Microsystems develops high-tech precision microscopes and imaging systems for life science research, biotechnology, medicine, and pharmaceutical analysis of microstructures and nanostructures. Their portfolio includes digital microscopes for biological sciences, materials analysis, and industrial quality assurance, enhanced by machine learning and automation. As part of Danaher Corporation, they operate globally with headquarters in Wetzlar, Germany, and presence in over 100 countries.
Frequently asked questions
- What microscopy solutions does Leica offer for pharmaceutical R&D?
- Leica provides advanced microscopes for life science research, biotechnology, and analysis of microstructures/nanostructures, including digital series like DM4000 B/DM6000 B for biological sciences and imaging cameras with high resolution and fast live speeds.
- What are Leica Microsystems' global capabilities and manufacturing footprint?
- Headquartered in Wetzlar, Germany, Leica has 12 manufacturing facilities in 7 countries, sales/service in 19 countries, and representation in over 100 countries through an international dealer network.
- Is Leica Microsystems compliant with regulatory standards for pharma?
- As a Danaher Corporation company with 175+ years in scientific instruments and a capability statement (EIN: 22-2701363), Leica adheres to high-quality standards for optics and systems used in regulated fields like medicine, biotech, and forensics.